Cargando…
Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice Model
OBJECTIVE: To evaluate the ability of the glycolytic enzyme alpha-enolase (ENO1) or its immunodominant peptide (pEP1) to reduce the severity of CIA in DBA/1 mice when injected in a prophylactic way. METHODS: Mice were treated with mouse ENO1 or pEP1 one day prior to collagen II immunization. Clinica...
Autores principales: | Guillou, Clément, Derambure, Céline, Fréret, Manuel, Verdet, Mathieu, Avenel, Gilles, Golinski, Marie-Laure, Sabourin, Jean-Christophe, Loarer, François Le, Adriouch, Sahil, Boyer, Olivier, Lequerré, Thierry, Vittecoq, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547710/ https://www.ncbi.nlm.nih.gov/pubmed/26302382 http://dx.doi.org/10.1371/journal.pone.0136359 |
Ejemplares similares
-
Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function
por: Guillou, Clément, et al.
Publicado: (2016) -
Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors
por: Golinski, Marie-Laure, et al.
Publicado: (2015) -
Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis
por: Derambure, Céline, et al.
Publicado: (2020) -
Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing In Vivo Epitopes of Its γ Chain One of Which Is Not Cross Reactive With Anti-Citrullinated Protein Antibodies
por: Brevet, Pauline, et al.
Publicado: (2021) -
Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study
por: Vittecoq, Olivier, et al.
Publicado: (2019)